ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1942

$568K Total Retail Price of All Prescriptions

Rank: 49 out of 1942

474 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 607 579 1 5
LISINOPRIL 506 478 2 2
SIMVASTATIN 474 443 3 1
WARFARIN SODIUM 462 449 4 11
OMEPRAZOLE 406 368 5 4
METOPROLOL TARTRATE 374 364 6 9
LEVOTHYROXINE SODIUM 329 300 7 3
HYDROCHLOROTHIAZIDE 282 276 8 8
METOPROLOL SUCCINATE 250 241 9 13
METFORMIN HCL 244 207 10 10
POLYETHYLENE GLYCOL 3350 224 219 11 28
POTASSIUM CHLORIDE 197 181 12 17
MIRTAZAPINE 187 171 13 38
AMLODIPINE BESYLATE 177 177 14 6
TAMSULOSIN HCL 168 166 15 29
RANITIDINE HCL 143 133 16 31
ATORVASTATIN CALCIUM 143 129 16 14
CITALOPRAM HBR 127 111 18 15
TRAMADOL HCL 123 122 19 19
ATENOLOL 123 122 19 7
HYDROCODONE-ACETAMINOPHEN 122 108 S3 21 12
GABAPENTIN 118 109 22 16
CLOPIDOGREL 109 109 23 55
ALLOPURINOL 108 104 24 26
CARBIDOPA-LEVODOPA 105 105 25 64
ALENDRONATE SODIUM 102 89 26 21
PLAVIX 98 98 27 83
NOVOFINE AUTOCOVER 96 96 28 232
SERTRALINE HCL 96 96 28 20
NAMENDA 94 94 30 51
DILTIAZEM 24HR ER 93 93 31 172
MORPHINE SULFATE ER 88 75 S2 32 88
DONEPEZIL HCL 88 88 32 30
FENTANYL 81 81 S2 34 47
CARVEDILOL 80 68 35 39
NOVOLOG FLEXPEN 79 73 36 107
DIOVAN 71 71 37 44
LANTUS SOLOSTAR 71 61 37 54
SPIRONOLACTONE 70 70 39 59
TRAZODONE HCL 69 46 40 24
PREDNISONE 69 69 40 27
DOXAZOSIN MESYLATE 67 67 42 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 59 43 22
CYMBALTA 57 56 44 62
LOSARTAN POTASSIUM 54 48 45 18
TRAMADOL HCL-ACETAMINOPHEN 52 50 46 230
AVODART 50 50 47 211
PANTOPRAZOLE SODIUM 50 45 47 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.